Cutler Group LP Glycomimetics Inc Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2019 Oct 28, 2019	SELL	$2.8 - $12.85 $7,839 - $35,980	-2,800 Reduced 70.0%	1,200 $1,000
Q1 2019 May 10, 2019	BUY	$9.96 - $13.44 $39,840 - $53,760	4,000 New	4,000 $3,000
Q4 2018 Feb 05, 2019	SELL	$8.47 - $14.71 $76,230 - $132,390	-9,000 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$13.7 - $17.12 $54,800 - $68,480	4,000 Added 80.0%	9,000 $25,000
Q2 2018 Aug 10, 2018	SELL	$14.63 - $19.19 $52,668 - $69,084	-3,600 Reduced 41.86%	5,000 $9,000
Q1 2018 May 11, 2018	SELL	$16.06 - $25.35 $6,423 - $10,140	-400 Reduced 4.44%	8,600 $22,000
Q4 2017 Jan 17, 2018	BUY	$10.51 - $17.22 $94,590 - $154,980	9,000	9,000 $23,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.8M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.